Skip to main content
. 2019 Aug 16;98(33):e16785. doi: 10.1097/MD.0000000000016785

Figure 2.

Figure 2

Reported frequency of serious adverse events (SAEs) associated with the use of anti-vascular endothelial growth factor (anti-VEGF) agents, by year. VEGF = vascular endothelial growth factor.